← Back to Search

SENSE Theatre for Autism

N/A
Waitlist Available
Led By Blythe A Corbett, Ph.D.
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Peers must be at least 18 years of age
Confederates must be at least 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pretest, week 5, week 11, two-month follow-up
Awards & highlights

Study Summary

This trial found that the theatre play intervention has the potential to improve social cognition and behavior for adults with autism spectrum disorder.

Who is the study for?
This trial is for adults with Autism Spectrum Disorder (ASD) who are not in educational programs. They must have an IQ of 70 or above, be diagnosed by a specialist confirmed with ADOS-2, and show interest in improving social skills. Excluded are those with suicidal tendencies, uncontrolled aggression, intellectual impairment below the set IQ threshold, or previous SENSE Theatre participants.Check my eligibility
What is being tested?
SENSE Theatre is being tested as an intervention to improve social competence in adults with ASD. It uses peer models, scripted and improvised role-play from theatre techniques to enhance social cognition and behavior through repeated practice.See study design
What are the potential side effects?
There may not be traditional medical side effects since this is a behavioral intervention; however, participants might experience anxiety or stress during performances or interactions. The impact varies among individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 18 years old.
Select...
I am at least 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pretest, week 5, week 11, two-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and pretest, week 5, week 11, two-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Contextual Assessment of Social Skills
Change in Incidental Face Memory
Change in Social Responsiveness Scale - Parent (SRS)
+1 more
Secondary outcome measures
Adaptive Behavior Assessment System (ABAS) - Parent-Report
Adaptive Behavior Assessment System (ABAS) - Self-Report
Cambridge Face Memory Test
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SENSE TheatreExperimental Treatment1 Intervention
A peer-mediated, theatre-based intervention designed to improve social cognition and behavior.
Group II: Waitlist Control GroupActive Control1 Intervention
This group will not receive the intervention during the testing phase of the intervention but will eventually receive the theatre intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SENSE Theatre
2014
N/A
~460

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,119 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,437 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,034 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,279 Patients Enrolled for Autism Spectrum Disorder
Blythe A Corbett, Ph.D.Principal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
136 Patients Enrolled for Autism Spectrum Disorder

Media Library

SENSE Theatre Clinical Trial Eligibility Overview. Trial Name: NCT04349644 — N/A
Autism Spectrum Disorder Research Study Groups: SENSE Theatre, Waitlist Control Group
Autism Spectrum Disorder Clinical Trial 2023: SENSE Theatre Highlights & Side Effects. Trial Name: NCT04349644 — N/A
SENSE Theatre 2023 Treatment Timeline for Medical Study. Trial Name: NCT04349644 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age requirement for participation in this investigation?

"As per the stipulated enrolment guidelines, only those aged 18-35 can qualify for this clinical trial."

Answered by AI

What is the principal aim of this research project?

"This trial aims to evaluate changes in Incidental Face Memory over the course of 11 weeks. Secondary outcomes include Cambridge Face Memory Test, Wechsler Memory Scale Face Memory Delay Test, and Wechsler Memory Scale Face Memory Test - all three are standardized measures which assess a participant's ability to remember faces among an array of presented images. An increase in raw score indicates improvement in face memory."

Answered by AI

What qualifications are necessary for participants in this trial to meet?

"This medical study is looking for 40 individuals aged 18 to 35 with a diagnosis of Autism Spectrum Disorder (DSM-V criteria) confirmed by the Autism Diagnostic Observation Schedule. Furthermore, only participants without educational opportunities and those with an IQ greater than 70 shall be eligible for enrollment."

Answered by AI

Are there currently openings available in this medical experiment?

"Precisely. According to clinicaltrials.gov, the trial has been recruiting since October 21st 2020 and was most recently updated on February 17th 2022. The study is looking for 40 individuals from 1 particular site."

Answered by AI

What is the scope of participants in this clinical exploration?

"Affirmative. According to the data found on clinicaltrials.gov, this trial is actively recruiting participants and was first posted on October 21st 2020. 40 individuals need to be sourced from 1 location in order for the study to move forward."

Answered by AI

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Enhancing Social Competence in Adults With Autism
Blythe Corbett 2020. "Enhancing Social Competence in Adults With Autism". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04349644.
All > Asd > Autism
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top